---
sidebar_position: 35
---

# æ–‡ç» 35ï¼šAutomated Literature Screening for Hepatocellular Carcinoma Treatment Through Integration of 3 Large Language Models

**English Title**: Automated Literature Screening for Hepatocellular Carcinoma Treatment Through Integration of 3 Large Language Models

**ä¸­æ–‡æ¨™é¡Œ**: é€šéæ•´åˆ 3 å€‹å¤§å‹èªè¨€æ¨¡å‹é€²è¡Œè‚ç´°èƒç™Œæ²»ç™‚çš„è‡ªå‹•æ–‡ç»ç¯©é¸
**PMID**: 40921065
**æœŸåˆŠ**: JMIR medical informatics
**è©•åˆ†**: 9
**æ‡‰ç”¨é ˜åŸŸ**: ä½é™¢/ç ”ç©¶
**DOI**: https://doi.org/10.2196/76252

---

## ğŸ“Œ ç¬¬ä¸€å¼µï¼šæ ¸å¿ƒè§€é»å¡

### ä¸»è¦ç™¼ç¾
è‡ªå‹•åŒ–ç³»çµ±æ€§æ–‡ç»å›é¡§

### æ–‡ç»æ‘˜è¦ï¼ˆAbstractï¼‰
BACKGROUND: Primary liver cancer, particularly hepatocellular carcinoma (HCC), poses significant clinical challenges due to late-stage diagnosis, tumor heterogeneity, and rapidly evolving therapeutic strategies. While systematic reviews and meta-analyses are essential for updating clinical guidelines, their labor-intensive nature limits timely evidence synthesis. OBJECTIVE: This study proposes an automated literature screening workflow powered by large language models (LLMs) to accelerate evidence synthesis for HCC treatment guidelines. METHODS: We developed a tripartite LLM framework integrating Doubao-1.5-pro-32k, Deepseek-v3, and DeepSeek-R1-Distill-Qwen-7B to simulate collaborative decision-making for study inclusion and exclusion. The system was evaluated across 9 reconstructed datasets derived from published HCC meta-analyses, with performance assessed using accuracy, agreement metrics (Îº and prevalence-adjusted bias-adjusted Îº), recall, precision, F RESULTS: The framework demonstrated good performance, with a weighted accuracy of 0.96 and substantial agreement (prevalence-adjusted bias-adjusted Îº=0.91), achieving high weighted recall (0.90) but modest weighted precision (0.15) and F CONCLUSIONS: This LLM-driven approach shows promise for accelerating evidence synthesis in HCC care by reducing screening time while maintaining methodological rigor. Key limitations related to clinical context sensitivity and error propagation highlight the need for reinforcement learning integration and domain-specific fine-tuning. LLM agent architectures with reinforcement learning offer a practical path for streamlining guideline updates, though further optimization is needed to improve specialization and reliability in complex clinical settings.

### ä¸­æ–‡æ‘˜è¦
èƒŒæ™¯ï¼šåŸç™¼æ€§è‚ç™Œï¼Œç‰¹åˆ¥æ˜¯è‚ç´°èƒç™Œï¼ˆHCCï¼‰ï¼Œç”±æ–¼æ™šæœŸè¨ºæ–·ã€è…«ç˜¤ç•°è³ªæ€§å’Œå¿«é€Ÿæ¼”è®Šçš„æ²»ç™‚ç­–ç•¥ï¼Œå¸¶ä¾†äº†é‡å¤§è‡¨åºŠæŒ‘æˆ°ã€‚é›–ç„¶ç³»çµ±æ€§å›é¡§å’Œçµ±åˆåˆ†æå°æ–¼æ›´æ–°è‡¨åºŠæŒ‡å¼•è‡³é—œé‡è¦ï¼Œä½†å…¶å‹å‹•å¯†é›†çš„æ€§è³ªé™åˆ¶äº†åŠæ™‚çš„è­‰æ“šç¶œåˆã€‚ç›®çš„ï¼šæœ¬ç ”ç©¶æå‡ºä¸€å€‹ç”±å¤§å‹èªè¨€æ¨¡å‹ï¼ˆLLMï¼‰é©…å‹•çš„è‡ªå‹•åŒ–æ–‡ç»ç¯©é¸å·¥ä½œæµç¨‹ï¼Œä»¥åŠ é€Ÿ HCC æ²»ç™‚æŒ‡å¼•çš„è­‰æ“šç¶œåˆã€‚æ–¹æ³•ï¼šæˆ‘å€‘é–‹ç™¼äº†ä¸€å€‹ä¸‰æ–¹ LLM æ¡†æ¶ï¼Œæ•´åˆ Doubao-1.5-pro-32kã€Deepseek-v3 å’Œ DeepSeek-R1-Distill-Qwen-7Bï¼Œä»¥æ¨¡æ“¬ç ”ç©¶ç´å…¥å’Œæ’é™¤çš„å”ä½œæ±ºç­–ã€‚è©²ç³»çµ±åœ¨å¾å·²ç™¼è¡¨çš„ HCC çµ±åˆåˆ†æè¡ç”Ÿçš„ 9 å€‹é‡å»ºæ•¸æ“šé›†ä¸Šé€²è¡Œè©•ä¼°ï¼Œä½¿ç”¨æº–ç¢ºåº¦ã€ä¸€è‡´æ€§æŒ‡æ¨™ï¼ˆÎº å’Œç¶“æ‚£ç—…ç‡èª¿æ•´çš„åå·®èª¿æ•´ Îºï¼‰ã€å¬å›ç‡ã€ç²¾ç¢ºåº¦ã€F å€¼è©•ä¼°æ€§èƒ½ã€‚çµæœï¼šè©²æ¡†æ¶é¡¯ç¤ºå‡ºè‰¯å¥½çš„æ€§èƒ½ï¼ŒåŠ æ¬Šæº–ç¢ºåº¦ç‚º 0.96ï¼Œå…·æœ‰å¯¦è³ªæ€§ä¸€è‡´æ€§ï¼ˆç¶“æ‚£ç—…ç‡èª¿æ•´çš„åå·®èª¿æ•´ Îº=0.91ï¼‰ï¼Œå¯¦ç¾äº†é«˜åŠ æ¬Šå¬å›ç‡ï¼ˆ0.90ï¼‰ï¼Œä½†åŠ æ¬Šç²¾ç¢ºåº¦ï¼ˆ0.15ï¼‰å’Œ F å€¼è¼ƒä½ã€‚çµè«–ï¼šé€™ç¨® LLM é©…å‹•çš„æ–¹æ³•é€éåœ¨ä¿æŒæ–¹æ³•å­¸åš´è¬¹æ€§çš„åŒæ™‚ç¸®çŸ­ç¯©é¸æ™‚é–“ï¼Œç‚ºåŠ é€Ÿ HCC ç…§è­·ä¸­çš„è­‰æ“šç¶œåˆé¡¯ç¤ºå‡ºå¸Œæœ›ã€‚èˆ‡è‡¨åºŠæƒ…å¢ƒæ•æ„Ÿæ€§å’Œèª¤å·®å‚³æ’­ç›¸é—œçš„é—œéµé™åˆ¶çªé¡¯äº†å¼·åŒ–å­¸ç¿’æ•´åˆå’Œç‰¹å®šé ˜åŸŸå¾®èª¿çš„éœ€æ±‚ã€‚å…·æœ‰å¼·åŒ–å­¸ç¿’çš„ LLM ä»£ç†æ¶æ§‹ç‚ºç°¡åŒ–æŒ‡å¼•æ›´æ–°æä¾›äº†å¯¦ç”¨è·¯å¾‘ï¼Œå„˜ç®¡éœ€è¦é€²ä¸€æ­¥å„ªåŒ–ä»¥æ”¹å–„è¤‡é›œè‡¨åºŠç’°å¢ƒä¸­çš„å°ˆæ¥­åŒ–å’Œå¯é æ€§ã€‚

### é—œéµæ•¸æ“š
- **ç ”ç©¶é¡å‹**: æœªåˆ†é¡
- **åœ‹å®¶/åœ°å€**: å¾…æŸ¥
- **ç™¼è¡¨å¹´ä»½**: å¾…æŸ¥
- **ROI æ•¸å€¼**: ç„¡æ•¸å€¼

### æ ¸å¿ƒå‰µæ–°é»
æœ¬ç ”ç©¶çš„ä¸»è¦å‰µæ–°åœ¨æ–¼ï¼šè‡ªå‹•åŒ–ç³»çµ±æ€§æ–‡ç»å›é¡§

---

## âœï¸ ç¬¬äºŒå¼µï¼šParaphrase å¡

### ç ”ç©¶ç›®çš„èˆ‡æ–¹æ³•
æœ¬ç ”ç©¶èšç„¦æ–¼ä½é™¢/ç ”ç©¶é ˜åŸŸï¼Œæ—¨åœ¨æ¢è¨ AI æŠ€è¡“åœ¨é†«ç™‚å ´æ™¯ä¸­çš„æ‡‰ç”¨ã€‚

### ä¸»è¦è²¢ç»
ç ”ç©¶æå‡ºäº†è‡ªå‹•åŒ–ç³»çµ±æ€§æ–‡ç»å›é¡§ï¼Œç‚ºè‡¨åºŠå¯¦è¸æä¾›äº†æ–°çš„è§£æ±ºæ–¹æ¡ˆã€‚

### æŠ€è¡“ç‰¹é»
- æ‡‰ç”¨å ´æ™¯ï¼šä½é™¢/ç ”ç©¶
- å‰µæ–°ç¨‹åº¦ï¼šè©•åˆ† 9/10
- æœŸåˆŠå½±éŸ¿ï¼šç™¼è¡¨æ–¼ JMIR medical informatics

---

## â“ ç¬¬ä¸‰å¼µï¼šå•ç­”å¡

### Q1: é€™é …ç ”ç©¶è§£æ±ºäº†ä»€éº¼å•é¡Œï¼Ÿ
A: æœ¬ç ”ç©¶é‡å°ä½é™¢/ç ”ç©¶é ˜åŸŸçš„æŒ‘æˆ°ï¼Œæå‡ºäº†åŸºæ–¼ AI çš„è§£æ±ºæ–¹æ¡ˆã€‚

### Q2: æ¡ç”¨äº†ä»€éº¼æŠ€è¡“æ–¹æ³•ï¼Ÿ
A: è‡ªå‹•åŒ–ç³»çµ±æ€§æ–‡ç»å›é¡§

### Q3: ç ”ç©¶çš„ä¸»è¦æˆæœæ˜¯ä»€éº¼ï¼Ÿ
A: ç ”ç©¶ç²å¾—äº† 9 åˆ†çš„å°ˆå®¶è©•åˆ†ï¼Œè­‰æ˜äº†å…¶åœ¨ä½é™¢/ç ”ç©¶é ˜åŸŸçš„æ‡‰ç”¨åƒ¹å€¼ã€‚

### Q4: æœ‰å“ªäº›å¯¦éš›æ‡‰ç”¨å ´æ™¯ï¼Ÿ
A: ä¸»è¦æ‡‰ç”¨æ–¼ä½é™¢/ç ”ç©¶ï¼Œå¯ç”¨æ–¼æ”¹å–„é†«ç™‚æœå‹™å“è³ªå’Œæ•ˆç‡ã€‚

---

## ğŸ¤” ç¬¬å››å¼µï¼šä¾‹å¤–å¡

### æ½›åœ¨é™åˆ¶
1. **ç ”ç©¶ç¯„åœ**: ç ”ç©¶è©•åˆ†ç‚º 9/10ï¼Œå¯èƒ½å­˜åœ¨æ”¹é€²ç©ºé–“
2. **åœ°å€å·®ç•°**: ç ”ç©¶ä¾†è‡ªå¾…æŸ¥ï¼Œå…¶ä»–åœ°å€é©ç”¨æ€§éœ€é©—è­‰
3. **ROI æ•¸æ“š**: ç„¡æ•¸å€¼ï¼Œç¶“æ¿Ÿæ•ˆç›Šè©•ä¼°å¯èƒ½ä¸å®Œæ•´

### éœ€è¦é€²ä¸€æ­¥æ¢è¨çš„å•é¡Œ
1. è©²æŠ€è¡“åœ¨ä¸åŒè¦æ¨¡é†«é™¢çš„é©ç”¨æ€§å¦‚ä½•ï¼Ÿ
2. é•·æœŸä½¿ç”¨çš„æ•ˆæœå’Œç©©å®šæ€§æ˜¯å¦ç¶“éé©—è­‰ï¼Ÿ
3. èˆ‡ç¾æœ‰ç³»çµ±æ•´åˆæ™‚å¯èƒ½é¢è‡¨å“ªäº›æŒ‘æˆ°ï¼Ÿ

### æ‰¹åˆ¤æ€§æ€è€ƒ
- **æŠ€è¡“æˆç†Ÿåº¦**: éœ€è¦è©•ä¼°å¾ç ”ç©¶åˆ°å¯¦éš›éƒ¨ç½²çš„è·é›¢
- **æˆæœ¬æ•ˆç›Š**: ç„¡æ•¸å€¼ï¼Œéœ€è¦æ›´è©³ç´°çš„ç¶“æ¿Ÿåˆ†æ
- **å€«ç†è€ƒé‡**: AI åœ¨ä½é™¢/ç ”ç©¶æ‡‰ç”¨æ™‚çš„å€«ç†å’Œéš±ç§å•é¡Œ
- **å¯æ¨å»£æ€§**: ç ”ç©¶çµæœåœ¨å…¶ä»–é†«ç™‚å ´æ™¯çš„é©ç”¨æ€§

---

## ğŸ“š åƒè€ƒè³‡è¨Š
- **PMID**: [40921065](https://pubmed.ncbi.nlm.nih.gov/40921065/)
- **DOI**: https://doi.org/10.2196/76252
- **æœŸåˆŠ**: JMIR medical informatics
